Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $123,345 | 3 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $123,345 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $19,170 | 2 | E.R. Squibb & Sons, L.L.C. ($19,170) |
| 2023 | $104,175 | 1 | E.R. Squibb & Sons, L.L.C. ($104,175) |
All Payment Transactions
3 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/07/2024 | E.R. Squibb & Sons, L.L.C. | — | — | Cash or cash equivalent | $4,875.00 | Research |
| Study: Retrospective Intracranial Analysis | ||||||
| 01/04/2024 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | — | Cash or cash equivalent | $14,295.00 | Research |
| Study: Phase III Stage III Unresectable NSCLC Combo - A Phase 3, Randomized, Open-Label Study to Compare Nivolumab Plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Dur • Category: Oncology | ||||||
| 06/07/2023 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | — | Cash or cash equivalent | $104,175.00 | Research |
| Study: Phase III Stage III Unresectable NSCLC Combo - A Phase 3, Randomized, Open-Label Study to Compare Nivolumab Plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Dur • Category: Oncology | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Phase III Stage III Unresectable NSCLC Combo - A Phase 3, Randomized, Open-Label Study to Compare Nivolumab Plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Dur | E.R. Squibb & Sons, L.L.C. | $118,470 | 2 |
| Retrospective Intracranial Analysis | E.R. Squibb & Sons, L.L.C. | $4,875 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 39 | 2,009 | 16,135 | $2.9M | $138,114 |
| 2022 | 46 | 2,433 | 29,817 | $3.8M | $208,665 |
| 2021 | 45 | 2,232 | 16,107 | $2.1M | $133,452 |
| 2020 | 42 | 1,970 | 11,920 | $1.2M | $86,627 |
All Medicare Procedures & Services
185 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 70553 | Mri scan of brain before and after contrast | Office | 2023 | 97 | 97 | $716,703 | $26,725 | 3.7% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 81 | 81 | $328,884 | $12,504 | 3.8% |
| 70543 | Mri scan of bone of eye socket, face, and/or neck before and after contrast | Office | 2023 | 32 | 32 | $195,031 | $10,230 | 5.2% |
| 72158 | Mri scan of lower spinal canal before and after contrast | Office | 2023 | 37 | 37 | $223,945 | $9,532 | 4.3% |
| 70450 | Ct scan head or brain without contrast | Facility | 2023 | 270 | 275 | $56,292 | $9,139 | 16.2% |
| 72157 | Mri scan of middle spinal canal before and after contrast | Office | 2023 | 25 | 25 | $195,246 | $7,589 | 3.9% |
| 70544 | Mri scan of blood vessels of head without contrast | Office | 2023 | 39 | 39 | $171,327 | $7,534 | 4.4% |
| 72141 | Mri scan of upper spinal canal without contrast | Office | 2023 | 41 | 42 | $173,407 | $6,200 | 3.6% |
| 70551 | Mri scan of brain without contrast | Office | 2023 | 33 | 33 | $133,542 | $5,493 | 4.1% |
| 72156 | Mri scan of upper spinal canal before and after contrast | Office | 2023 | 18 | 18 | $132,372 | $4,276 | 3.2% |
| 72146 | Mri scan of middle spinal canal without contrast | Office | 2023 | 28 | 29 | $129,826 | $4,032 | 3.1% |
| 71260 | Ct scan of chest with contrast | Facility | 2023 | 80 | 81 | $24,138 | $3,908 | 16.2% |
| 72125 | Ct scan of upper spine without contrast | Facility | 2023 | 97 | 98 | $23,618 | $3,752 | 15.9% |
| 70546 | Mri scan of blood vessels of head before and after contrast | Office | 2023 | 12 | 13 | $81,536 | $3,634 | 4.5% |
| A9585 | Injection, gadobutrol, 0.1 ml | Office | 2023 | 174 | 12,430 | $31,075 | $3,271 | 10.5% |
| 70547 | Mri scan of blood vessels of neck without contrast | Office | 2023 | 15 | 15 | $58,005 | $2,820 | 4.9% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 239 | 244 | $12,200 | $2,105 | 17.3% |
| 72131 | Ct scan of lower spine without contrast | Office | 2023 | 20 | 20 | $43,952 | $1,943 | 4.4% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 194 | 204 | $9,162 | $1,579 | 17.2% |
| 72125 | Ct scan of upper spine without contrast | Office | 2023 | 13 | 13 | $20,426 | $1,533 | 7.5% |
| 70491 | Ct scan of soft tissue of neck with contrast | Office | 2023 | 12 | 12 | $21,729 | $1,533 | 7.1% |
| 70486 | Ct scan of face without contrast | Office | 2023 | 11 | 11 | $17,680 | $1,364 | 7.7% |
| 71250 | Ct scan of chest without contrast | Facility | 2023 | 28 | 29 | $6,989 | $1,277 | 18.3% |
| 70486 | Ct scan of face without contrast | Facility | 2023 | 33 | 33 | $8,771 | $1,045 | 11.9% |
| 70450 | Ct scan head or brain without contrast | Office | 2023 | 12 | 12 | $18,476 | $1,041 | 5.6% |
About Dr. Shlomo Minkowitz, MD
Dr. Shlomo Minkowitz, MD is a Diagnostic Radiology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/23/2012. The National Provider Identifier (NPI) number assigned to this provider is 1386901742.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shlomo Minkowitz, MD has received a total of $123,345 in payments from pharmaceutical and medical device companies, with $19,170 received in 2024. These payments were reported across 3 transactions from 1 company. The most common payment nature is "" ($123,345).
As a Medicare-enrolled provider, Minkowitz has provided services to 8,644 Medicare beneficiaries, totaling 73,979 services with total Medicare billing of $566,858. Data is available for 4 years (2020–2023), covering 185 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Other Specialties Diagnostic Radiology
- Location New York, NY
- Active Since 04/23/2012
- Last Updated 08/15/2023
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1386901742
Products in Payments
- OPDIVO (Biological) $118,470
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in New York
Thomas Sos, Md, MD
Diagnostic Radiology — Payments: $4.6M
Martin Prince, Md, Phd, Facr, MD, PHD, FACR
Diagnostic Radiology — Payments: $2.0M
Dr. Lawrence Tanenbaum, M.d, M.D
Diagnostic Radiology — Payments: $1.5M
Dr. Peter Nelson, M.d, M.D
Diagnostic Radiology — Payments: $943,291
Sherelle Laifer-Narin, Md, MD
Diagnostic Radiology — Payments: $695,487
Marc Brown, Md, MD
Diagnostic Radiology — Payments: $586,273